Table 3 Estimated cost savings per patient with the use of immunonutrition
Cost Savings per Patient by Costing Method a | ||
|---|---|---|
Population | Cost Savings Due to Reduced Hospital LOS | Cost Savings Due to Lower Infectious Complication Rates |
Base-case estimates | ||
Waitzberg et al.[4]. | $6,000 | $3,300 |
ΔLOS = 2.18; ICR, 14.71% vs. 31.32% | ||
Estimates using lower LOS and infectious complication rates for the control populationb | ||
Upper + lower GI | $3,200 | $1,600 |
ΔLOS = 1.21; ICR, 5.2% vs. 11.2% | ||
Upper GI only | $6,300 | $4,300 |
ΔLOS = 1.78; ICR, 7.9% vs.17.1% | ||
Lower GI only | $2,800 | $1,200 |
ΔLOS = 1.14; ICR, 4.8% vs. 10.4% |